Brian Matthew Hatcher Files Initial Form 3 as President, Recon, SET, CMFT at Zimmer Biomet

Executive Summary

On October 5, 2026, Brian Matthew Hatcher filed an initial statement of beneficial ownership (Form 3) with the SEC regarding his position at Zimmer Biomet Holdings, Inc. ($ZBH). The filing establishes his baseline ownership following his appointment as President, Recon, SET, CMFT, effective October 1, 2026.

Reported Holdings Breakdown

Direct Non-Derivative Equity

• Common Stock: 5,988 shares held directly.

Derivative Securities & Future Rights

Mr. Hatcher reported an extensive portfolio of restricted stock units (RSUs) and stock options:

• Restricted Stock Units (RSUs):

  • 816 RSUs vesting on February 20, 2027.
  • 2,465 RSUs (1,233 vesting Feb 25, 2027; 1,232 vesting Feb 25, 2028).
  • 943 RSUs (472 vesting May 1, 2027; 471 vesting May 1, 2028).
  • 6,201 RSUs vesting annually over three years starting February 20, 2027.
  • Total RSUs: 10,425 underlying shares of Common Stock.

• Employee Stock Options (Right to Buy - Fully Vested):

  • 2,156 options at $120.04 (expiring Feb 26, 2029)
  • 2,448 options at $152.84 (expiring Feb 21, 2030)
  • 2,121 options at $158.90 (expiring Feb 25, 2031)
  • 7,035 options at $117.22 (expiring Feb 18, 2032)
  • 575 options at $118.25 (expiring Mar 21, 2027)
  • 1,407 options at $111.14 (expiring Mar 01, 2028)
  • 857 options at $111.03 (expiring Mar 20, 2028)
  • Total Options: 16,599 option contracts.

Market and Governance Impact

As an initial Form 3 filing, this document does not reflect open-market buying or selling activity, but rather registers the insider's initial holdings upon becoming an executive officer subject to Section 16 reporting. Consequently, the trading significance is categorized as Low.